NCPA has partnered with the National Association of Boards of Pharmacy, the University of Houston College of Pharmacy, and others to create guidelines for pharmacies on dispensing buprenorphine for OUD treatment. The draft is open for public comments through May 31. We hope you’ll take this opportunity to weigh in on issues, challenges, and barriers regarding patient access to medications for opioid use disorder in community pharmacy. The final guidelines will aim to provide recommendations to overcome these challenges.
NCPA
